How easily can deadly bird flu spread from cows to people? We're still not sure

Publicly released:
International
CC-0. https://www.pexels.com/photo/chickens-with-cow-in-the-background-7202568/
CC-0. https://www.pexels.com/photo/chickens-with-cow-in-the-background-7202568/

Previous research has suggested that deadly H5N1 bird flu in cows can spread to people relatively easily after showing that the virus can bind to a type of acids found in human airways, called sialic acids, and could then be spread to ferrets. That suggested the virus could soon start to spread between different mammals, including us, potentially leading to a new global pandemic. However, a pair of new studies has cast doubt on those findings. The first, by US and UK researchers, found H5N1 in cows binds poorly to human sialic acids, suggesting the virus cannot spread easily from cows to people. The second study, by US scientists, looked at whether the virus binds more easily to receptors in birds than mammals, even after infecting cows, and found that to be the case.  The team found no evidence of a shift towards infecting humans or other mammals as the virus has spread and evolved, although this should be the subject of continuous monitoring, they say. Finally, the authors of the original study which suggested the virus could spread between mammals respond to the new work. Differences in the methods used may explain the contrasting findings, they say, and we should not be complacent about the potential for H5N1 to become the next global pandemic.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page Paper 1: The URL will go live after the embargo ends
Research Springer Nature, Web page Paper 2. The URL will go live after the embargo ends
Research Springer Nature, Web page Response to the new studies. The URL will go live after the embargo ends
Journal/
conference:
Nature
Organisation/s: Paper 1: University of Pennsylvania, USA. Paper 2: University of Georgia, USA. Response: University of Wisconsin-Madison, USA
Funder: Study 1: This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID), Department of Health and Human Services, under Contract No. 75N93021C00015 and NIAID grant number AI114730. Study 2: This research was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Award Number R01 AI165692 (G.-J.B.) and contract numbers 75N93021C00016 (R.J.W.) and 75N93021C00018 (S.M.T.; NIAID Centers for Excellence for Influenza Research and Response, CEIRR). Funding was obtained from ICRAD and ERA-NET co-funded under the European Union’s Horizon 2020 research and innovation programme under grant agreement 862605 (R.P.d.V.)
Media Contact/s
Contact details are only visible to registered journalists.